These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Current perspective in tuberculosis vaccine development for high TB endemic regions. Husain AA; Daginawala HF; Singh L; Kashyap RS Tuberculosis (Edinb); 2016 May; 98():149-58. PubMed ID: 27156631 [TBL] [Abstract][Full Text] [Related]
5. What's Old and New in Tuberculosis Vaccines for Children. Cranmer LM; Cotton MF; Day CL; Nemes E J Pediatric Infect Dis Soc; 2022 Oct; 11(Supplement_3):S110-S116. PubMed ID: 36314550 [TBL] [Abstract][Full Text] [Related]
6. Tuberculosis vaccine: A journey from BCG to present. Fatima S; Kumari A; Das G; Dwivedi VP Life Sci; 2020 Jul; 252():117594. PubMed ID: 32305522 [TBL] [Abstract][Full Text] [Related]
7. Tuberculosis vaccine. Sarhan MA Saudi Med J; 2010 Jan; 31(1):9-13. PubMed ID: 20062891 [TBL] [Abstract][Full Text] [Related]
10. Current and novel approaches to vaccine development against tuberculosis. Cayabyab MJ; Macovei L; Campos-Neto A Front Cell Infect Microbiol; 2012; 2():154. PubMed ID: 23230563 [TBL] [Abstract][Full Text] [Related]
11. Bacille Calmette Guérin (BCG) and new TB vaccines: Specific, cross-mycobacterial and off-target effects. Fritschi N; Curtis N; Ritz N Paediatr Respir Rev; 2020 Nov; 36():57-64. PubMed ID: 32958428 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study. Tseng CL; Oxlade O; Menzies D; Aspler A; Schwartzman K BMC Public Health; 2011 Jan; 11():55. PubMed ID: 21269503 [TBL] [Abstract][Full Text] [Related]
13. The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG? Martín C Eur Respir J; 2005 Jul; 26(1):162-7. PubMed ID: 15994403 [TBL] [Abstract][Full Text] [Related]
14. Novel vaccination strategies against tuberculosis. Andersen P; Kaufmann SH Cold Spring Harb Perspect Med; 2014 Jun; 4(6):. PubMed ID: 24890836 [TBL] [Abstract][Full Text] [Related]
15. Vaccination strategies to prevent tuberculosis in the new millennium: from BCG to new vaccine candidates. Franco-Paredes C; Rouphael N; del Rio C; Santos-Preciado JI Int J Infect Dis; 2006 Mar; 10(2):93-102. PubMed ID: 16377228 [TBL] [Abstract][Full Text] [Related]
16. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis? Moliva JI; Turner J; Torrelles JB Vaccine; 2015 Sep; 33(39):5035-41. PubMed ID: 26319069 [TBL] [Abstract][Full Text] [Related]
17. Tuberculosis vaccines: current status and future prospects. Fletcher H; McShane H Expert Opin Emerg Drugs; 2006 May; 11(2):207-15. PubMed ID: 16634697 [TBL] [Abstract][Full Text] [Related]
18. Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology. Kaufmann SHE Front Immunol; 2020; 11():316. PubMed ID: 32174919 [TBL] [Abstract][Full Text] [Related]
19. Recombinant live vaccine candidates against tuberculosis. Kaufmann SH; Gengenbacher M Curr Opin Biotechnol; 2012 Dec; 23(6):900-7. PubMed ID: 22483201 [TBL] [Abstract][Full Text] [Related]
20. Next-Generation Vaccines Based on Bacille Calmette-Guérin. Nieuwenhuizen NE; Kaufmann SHE Front Immunol; 2018; 9():121. PubMed ID: 29459859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]